Although many treatment regimens have been used to treat AMD [2]–[6], intravitreal injection of anti-vascular endothelial growth factor (VEGF) produced lesion improvement and better visual acuity in some patients [7], [8]. The gene discussed is VEGFA; the disease is age-related macular degeneration.